Literature DB >> 17224116

Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis.

Fasika Woreta1, Jennifer E Thorne, Douglas A Jabs, Sanjay R Kedhar, James P Dunn.   

Abstract

PURPOSE: To describe the frequencies of and risk factors for ocular complications and poor visual acuity at presentation in a cohort of patients with juvenile idiopathic arthritis (JIA)-associated uveitis.
DESIGN: Cross-sectional study.
METHODS: setting: Single-center, academic practice. study population: Seventy-five patients with JIA-associated uveitis were evaluated between July 1984 and August 2005. observation procedures: Data on patients diagnosed with JIA-associated uveitis were entered retrospectively into a database and analyzed. outcome measures: Visual acuity of 20/50 or worse or 20/200 or worse, and presence of ocular complications (including cataract, posterior synechiae, band keratopathy, elevated intraocular pressure, hypotony, macular edema, and epiretinal membrane) at presentation.
RESULTS: At presentation, ocular complications were seen in 67% of eyes affected by JIA-associated uveitis. Presence of > or =1+ anterior chamber flare, a positive antinuclear antibody (ANA), and a shorter duration between the diagnosis of arthritis and uveitis were significantly associated with the presence of ocular complication. The frequencies of 20/50 or worse and of 20/200 or worse visual acuities at presentation in affected eyes were 36% and 24%, respectively. The presence of > or =1+ anterior chamber flare and a history of intraocular surgery before presentation were significantly associated with 20/50 or worse and 20/200 or worse vision. Presence of posterior synechiae also was associated with 20/200 or worse vision at presentation. The main causes of poor vision at presentation for affected eyes and better-seeing eyes were cataract, band keratopathy within the visual axis, and glaucoma.
CONCLUSIONS: Ocular complications and poor vision at presentation were common in our patients with JIA-related uveitis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17224116      PMCID: PMC1892578          DOI: 10.1016/j.ajo.2006.11.025

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  20 in total

1.  An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood.

Authors:  Clive Edelsten; Vickie Lee; Christopher R Bentley; Jack J Kanski; Elizabeth M Graham
Journal:  Br J Ophthalmol       Date:  2002-01       Impact factor: 4.638

2.  [Epidemiology of uveitis in juvenile idiopathic arthritis from a national paediatric rheumatologic and ophthalmologic database].

Authors:  A Heiligenhaus; M Niewerth; A Mingels; G Ganser; A Thon; U Pleyer; K Greiner; K Minden
Journal:  Klin Monbl Augenheilkd       Date:  2005-12       Impact factor: 0.700

3.  Early predictors of severe course of uveitis in oligoarticular juvenile idiopathic arthritis.

Authors:  Francesco Zulian; Giorgia Martini; Fernanda Falcini; Valeria Gerloni; Maria Elisabetta Zannin; Luisa Pinello; Flavio Fantini; Paola Facchin
Journal:  J Rheumatol       Date:  2002-11       Impact factor: 4.666

4.  Systemic steroid prophylaxis for cataract surgery in patients with posterior uveitis.

Authors:  K Barton; A J Hall; P H Rosen; R J Cooling; S Lightman
Journal:  Ocul Immunol Inflamm       Date:  1994       Impact factor: 3.070

5.  Uveitis in juvenile arthritis.

Authors:  A T Berk; N Koçak; E Unsal
Journal:  Ocul Immunol Inflamm       Date:  2001-12       Impact factor: 3.070

6.  Iridocyclitis associated with juvenile rheumatoid arthritis.

Authors:  S N Key; S J Kimura
Journal:  Am J Ophthalmol       Date:  1975-09       Impact factor: 5.258

7.  Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease.

Authors:  Angelo Ravelli; Enrico Felici; Silvia Magni-Manzoni; Angela Pistorio; Cristina Novarini; Elena Bozzola; Stefania Viola; Alberto Martini
Journal:  Arthritis Rheum       Date:  2005-03

8.  Factors related to severe uveitis at diagnosis in children with juvenile idiopathic arthritis in a screening program.

Authors:  Audrey Chia; Vickie Lee; Elizabeth M Graham; Clive Edelsten
Journal:  Am J Ophthalmol       Date:  2003-06       Impact factor: 5.258

Review 9.  Diagnosis and treatment of juvenile idiopathic arthritis-associated uveitis.

Authors:  C Stephen Foster
Journal:  Curr Opin Ophthalmol       Date:  2003-12       Impact factor: 3.761

Review 10.  Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.

Authors:  Douglas A Jabs; Robert B Nussenblatt; James T Rosenbaum
Journal:  Am J Ophthalmol       Date:  2005-09       Impact factor: 5.258

View more
  46 in total

Review 1.  Juvenile idiopathic arthritis-associated uveitis.

Authors:  Ying Qian; Nisha R Acharya
Journal:  Curr Opin Ophthalmol       Date:  2010-11       Impact factor: 3.761

2.  Incidence rates and risk factors for ocular complications and vision loss in HLA-B27-associated uveitis.

Authors:  Allison R Loh; Nisha R Acharya
Journal:  Am J Ophthalmol       Date:  2010-10       Impact factor: 5.258

Review 3.  Uveitis in juvenile idiopathic arthritis.

Authors:  Arnd Heiligenhaus; Kirsten Minden; Dirk Föll; Uwe Pleyer
Journal:  Dtsch Arztebl Int       Date:  2015-02-06       Impact factor: 5.594

Review 4.  Optical coherence tomography imaging in uveitis.

Authors:  Sumru Onal; Ilknur Tugal-Tutkun; Piergiorgio Neri; Carl P Herbort
Journal:  Int Ophthalmol       Date:  2013-07-09       Impact factor: 2.031

Review 5.  The Future Is Now: Biologics for Non-Infectious Pediatric Anterior Uveitis.

Authors:  Melissa A Lerman; C Egla Rabinovich
Journal:  Paediatr Drugs       Date:  2015-08       Impact factor: 3.022

Review 6.  The role of sex in uveitis and ocular inflammation.

Authors:  Ian Y L Yeung; Nicholas A Popp; Chi-Chao Chan
Journal:  Int Ophthalmol Clin       Date:  2015

7.  Timing of infliximab and adalimumab initiation despite methotrexate in children with chronic non-infectious anterior uveitis.

Authors:  Courtney McCracken; Steven Yeh; Kirsten Jenkins; Curtis Travers; Daneka Stryker; Steven Tommasello; Kelly A Rouster-Stevens; Scott R Lambert; Sampath Prahalad; Carolyn Drews-Botsch; Sheila T Angeles-Han
Journal:  Eye (Lond)       Date:  2018-11-28       Impact factor: 3.775

8.  Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study.

Authors:  Anthony C Gregory; John H Kempen; Ebenezer Daniel; R Oktay Kaçmaz; C Stephen Foster; Douglas A Jabs; Grace A Levy-Clarke; Robert B Nussenblatt; James T Rosenbaum; Eric B Suhler; Jennifer E Thorne
Journal:  Ophthalmology       Date:  2012-10-11       Impact factor: 12.079

9.  Uveitis and juvenile idiopathic arthritis: A cohort study.

Authors:  David BenEzra; Evelyne Cohen; Francine Behar-Cohen
Journal:  Clin Ophthalmol       Date:  2007-12

10.  The Association of Race With Childhood Uveitis.

Authors:  Sheila T Angeles-Han; Courtney McCracken; Steven Yeh; Kirsten Jenkins; Daneka Stryker; Curtis Travers; Kelly Rouster-Stevens; Larry B Vogler; Scott R Lambert; Carolyn Drews-Botsch; Sampath Prahalad
Journal:  Am J Ophthalmol       Date:  2015-08-06       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.